The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population
Abstract
Background —Fibrinogen has been identified as an independent risk factor for cardiovascular disease and associated with traditional cardiovascular risk factors. Also, the role of elevated fibrinogen in thrombosis suggests that it may be on the causal pathway for certain risk factors to exert their effect. These associations remain incompletely characterized. Moreover, the optimal fibrinogen assay for risk stratification is uncertain. Methods and Results —In 2632 subjects from cycle 5 of the Framingham Offspring Population, fibrinogen levels were determined with a newly developed immunoprecipitation test (American Biogenetic Sciences) and the functional Clauss method. With the immunoprecipitation method, there were significant linear trends across fibrinogen tertiles ( P <0.001) for age, body mass index, smoking, diabetes mellitus, total cholesterol, HDL cholesterol, and triglycerides in men and women. The Clauss method had significant results ( P <0.030), except for triglycerides in men. Fibrinogen levels were higher for those with compared with those without cardiovascular disease. After covariate adjustment, fibrinogen remained significantly higher in those with cardiovascular disease with the use of the immunoprecipitation test ( P =0.035 and P =0.018 for men and women, respectively) but not with the Clauss method. Conclusions —Fibrinogen was associated with traditional cardiovascular risk factors. Elevation of fibrinogen may provide a mechanism for risk factors to exert their effect. Also, fibrinogen levels were higher among subjects with cardiovascular disease compared with those without disease. The immunoprecipitation test showed a stronger association with cardiovascular disease than the Clauss method, suggesting that it may be a useful screening tool to identify individuals at increased thrombotic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Meade, T. W., Brozovic, M., Chakrabarti, R. R., Haines, A. P., Imeson, J. D., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,939
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Fibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 593
Elevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Heinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563
Balleisen, L., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657877 · Cited by 346
Krobot, K., Hense, H. W., Cremer, P., Eberle, E., & Keil, U. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.7.780 · Cited by 223
Gordon, T., Moore, F. E., Shurtleff, D., & Dawber, T. R. (1959) · Journal of Chronic Diseases · doi:10.1016/0021-9681(59)90002-5 · Cited by 177
Lee, A. J., Lowe, G. D., Woodward, M., & Tunstall-Pedoe, H. (1993) · Heart · doi:10.1136/hrt.69.4.338 · Cited by 164
Burr, M. L., Holliday, R. M., FEHILY, A. M., & WHITEHEAD, P. J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060141 · Cited by 129
Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Green, D., Ruth, K. J., Folsom, A. R., & Liu, K. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.686 · Cited by 87
Baker, I. A., Eastham, R. D., Elwood, P. C., Etherington, M. D., O'Brien, J. R., & Sweetnam, P. M. (1982) · Heart · doi:10.1136/hrt.47.5.490 · Cited by 79
Fibrinogen in Obesity Before and After Weight Reduction
Ditschuneit, H., Flechtner‐Mors, M., & Adler, G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00119.x · Cited by 72
Barasch, E., Benderly, M., Graff, E., Behar, S., Reicher-Reiss, H., Caspi, A., Pelled, B., Reisin, L., Roguin, N., & Goldbourt, U. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00191-r · Cited by 51
Physical Activity and Fibrinogen Concentration in Newly Diagnosed NIDDM
Vanninen, E. J., Laitinen, J. H., & Uusitupa, M. I. J. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.1031 · Cited by 31
Associations between Plasma Fibrinogen Levels and Cardiovascular Risk Factors in Hypertensive Men
Fogari, R., Zoppi, A., Marasi, G., Vanasia, A., & Villa, G. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100410 · Cited by 19
Cited by
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
Delfino, R. J., Sioutas, C., & Malik, S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7938 · Cited by 931
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
Metadata
- Authors
- Stec, J. J., Silbershatz, H., Tofler, G. H., Matheney, T. H., Sutherland, P., Lipinska, I., Massaro, J. M., Wilson, P. F. W., Muller, J. E., & D’Agostino, R. B.
- Venue
- Circulation
- Published
- 2000-10-03
- Volume
- 102
- Issue
- 14
- Pages
- 1634-1638
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991509131
- Cited by
- 340
- References
- 20
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.